Related Experiment Video
Updated: May 9, 2026

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
p63, Sharp1, and HIFs: master regulators of metastasis in triple-negative breast cancer
Stefano Piccolo1, Elena Enzo, Marco Montagner
1Department of Molecular Medicine, School of Medicine, University of Padua, Padua, Italy.
Abstract:
Metastasis is the most significant cause of cancer-associated morbidity and mortality but remains poorly understood. Recent work revealed that metastasis of aggressive triple-negative breast cancers is suppressed by Sharp1, a factor that promotes degradation of hypoxia-inducible factors (HIF) and blunts HIF-induced malignant cell behavior.
Insights
Sharp1 protein suppresses metastasis in aggressive triple-negative breast cancers by degrading hypoxia-inducible factors (HIF), thus reducing malignant cell activity and improving patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastasis is a primary driver of cancer mortality.
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options.
- The molecular mechanisms underlying TNBC metastasis are not fully understood.
Purpose of the Study:
- To investigate the role of Sharp1 in suppressing metastasis of aggressive triple-negative breast cancers.
- To elucidate the mechanism by which Sharp1 affects hypoxia-inducible factors (HIF) and malignant cell behavior.
Main Methods:
- Utilized molecular biology techniques to study Sharp1 function in TNBC models.
- Investigated the interaction between Sharp1 and hypoxia-inducible factors (HIF).
- Assessed the impact of Sharp1 on cancer cell behavior and metastatic potential.
Main Results:
- Sharp1 was identified as a suppressor of metastasis in aggressive TNBC.
- Sharp1 promotes the degradation of hypoxia-inducible factors (HIF).
- Blunting HIF activity by Sharp1 reduces malignant cell behavior associated with metastasis.
Conclusions:
- Sharp1 plays a critical role in inhibiting metastasis in aggressive TNBC.
- Targeting the Sharp1-HIF pathway may offer a novel therapeutic strategy for TNBC.
- Further research into Sharp1 function could lead to improved treatments for metastatic breast cancer.
Related Concept Videos
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Regulation of Angiogenesis and Blood Supply

